Annual report pursuant to Section 13 and 15(d)

REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS - Disaggregation of net revenues (Details)

v3.23.1
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS - Disaggregation of net revenues (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 70,995 $ 63,134
Qbrexza    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 26,715 17,056
Accutane    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 18,373 10,053
Targadox    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 7,972 22,378
Amzeeq    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 7,242  
Ximino    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 4,957 8,247
Zilxi    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues 2,273  
Exelderm    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues $ 3,463 5,363
Other branded products    
REVENUES FROM CONTRACTS AND SIGNIFICANT CUSTOMERS    
Product revenues   $ 37